ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
23
views
0
references
Top references
cited by
3
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
3,379
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Age-related heterogeneity in Neutralising antibody responses to SARS-CoV-2 following BNT162b2 vaccination
Author(s):
DA Collier
,
IATM Ferreira
,
R. Datir
,
Collier
Publication date:
2021
Journal:
medRxiv
Read this article at
ScienceOpen
Bookmark
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Karger: Oncology
Data availability:
ScienceOpen disciplines:
Oncology & Radiotherapy
Comments
Comment on this article
Sign in to comment
Similar content
3,379
Engineering, Expression in Transgenic Plants and Characterisation of E559, a Rabies Virus-Neutralising Monoclonal Antibody
Authors:
Craig van Dolleweerd
,
Audrey Teh
,
Ashley C. Banyard
…
Herpes zoster viral infection after AZD1222 and BNT162b2 coronavirus disease 2019 mRNA vaccines: a case series
Authors:
D Koumaki
,
S.‐E. Krueger‐Krasagakis
,
M Papadakis
…
Early solicited adverse events following the BNT162b2 mRNA vaccination, a population survey from Saudi Arabia
Authors:
Abdulellah M. Almohaya
,
Farah Qari
,
Ghuzlan Zubaidi
…
See all similar
Cited by
3
Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study
Authors:
Leticia Monin
,
Adam Laing
,
Miguel Muñoz-Ruiz
…
Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort study
Authors:
Madhumita Shrotri
,
Maria Krutikov
,
Tom Palmer
…
Weak humoral immune reactivity among residents of long-term care facilities following one dose of the BNT162b2 mRNA COVID-19 vaccine
Authors:
Mark A. Brockman
,
Francis Mwimanzi
,
Yurou Sang
…
See all cited by